Literature DB >> 3526920

A dual-isotope technique for determination of in vivo ketone body kinetics.

J M Miles, W F Schwenk, K L McClean, M W Haymond.   

Abstract

"Total ketone body specific activity" has been widely used in studies of ketone body metabolism to circumvent so-called "isotope disequilibrium" between the two major ketone body pools, acetoacetate and beta-hydroxybutyrate. Recently, this approach has been criticized on theoretical grounds. In the present studies, [13C]acetoacetate and beta-[14C]hydroxybutyrate were simultaneously infused in nine mongrel dogs before and during an infusion of either unlabeled sodium acetoacetate or unlabeled sodium beta-hydroxybutyrate. Ketone body turnover was determined using total ketone body specific activity, total ketone body moles % enrichment, and an open two-pool model, both before and during the exogenous infusion of unlabeled ketone bodies. Basal ketone body turnover rates were significantly higher using [13C]acetoacetate than with either beta-[14C]hydroxybutyrate alone or the dual-isotope model (3.6 +/- 0.5 vs. 2.2 +/- 0.2 and 2.7 +/- 0.2 mumol X kg-1 X min-1, respectively, P less than 0.05). During exogenous infusion of unlabeled sodium acetoacetate, the dual-isotope model provided the best estimate of ketone body inflow, whereas 14C specific activity underestimated the known rate of acetoacetate infusion by 55% (P less than 0.02). During sodium beta-hydroxybutyrate infusion, [13C]-acetoacetate overestimated ketone body inflow by 55% (P = NS), while better results were obtained with 14C beta-hydroxybutyrate alone and the two-pool model. Ketone body interconversion as estimated by the dual-isotope technique increased markedly during exogenous ketone body infusion. In conclusion, significant errors in estimation of ketone body inflow were made using single-isotope techniques, whereas a dual-isotope model provided reasonably accurate estimates of ketone body inflow during infusion of exogenous acetoacetate and beta-hydroxybutyrate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3526920     DOI: 10.1152/ajpendo.1986.251.2.E185

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet.

Authors:  Nishanth E Sunny; Santhosh Satapati; Xiaorong Fu; TianTeng He; Roshi Mehdibeigi; Chandra Spring-Robinson; Joao Duarte; Matthew J Potthoff; Jeffrey D Browning; Shawn C Burgess
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-16       Impact factor: 4.310

2.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

3.  Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes.

Authors:  A Avogaro; R Nosadini; D M Bier; C Cobelli; G Toffolo; A Doria; A Valerio; H Christopherson
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar

4.  Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism.

Authors:  Santhosh Satapati; Tianteng He; Takeshi Inagaki; Matthew Potthoff; Matthew E Merritt; Victoria Esser; David J Mangelsdorf; Steven A Kliewer; Jeffrey D Browning; Shawn C Burgess
Journal:  Diabetes       Date:  2008-05-09       Impact factor: 9.461

5.  In Vivo Estimation of Ketogenesis Using Metabolic Flux Analysis-Technical Aspects and Model Interpretation.

Authors:  Stanislaw Deja; Blanka Kucejova; Xiaorong Fu; Jeffrey D Browning; Jamey D Young; Shawn Burgess
Journal:  Metabolites       Date:  2021-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.